Safety, growth, and support to healthy gut microbiota by an infant formula enriched with functional compounds. Issue 1 (February 2017)

• Record Type: Journal Article
• Authors: Civardi, Elisa; Garofoli, Francesca; Longo, Stefania; Mongini, Maria Elisa; Grenci, Beatrice; Mazzucchelli, Iolanda; Angelini, Micol; Castellazzi, Annamaria; Fasano, Francesca; Grinzato, Alessia; Fanos, Vassilios; Budelli, Andrea; Stronati, Mauro
• Is Part Of: Clinical nutrition. Volume 36:Issue 1(2017:Feb.)
• Page Start: 238
• Page End: 245
• Publication Date: 2017-02
• Subjects: Bifidobacteria -- Neonate -- Microbiota -- Formula; GE gestational age -- BIF species Bifidobacterium -- CLO species Clostridium -- MLMs mixed linear models -- MGLMs mixed general linear models -- MAR missed at random -- ESPGHAN European Society for Paediatric Gastroenterology, Hepatology and Nutrition -- WHO World Health Organization -- FDA food and drug administration; Critically ill -- Nutrition -- Periodicals; Diet therapy -- Periodicals; Parenteral feeding -- Periodicals; Enteral feeding -- Periodicals; Enteral Nutrition -- Periodicals; Parenteral Nutrition -- Periodicals; Metabolism -- Periodicals; Diétothérapie -- Périodiques; Alimentation parentérale -- Périodiques; Alimentation entérale -- Périodiques; Nutrition -- Périodiques; Diet therapy; Enteral feeding; Nutrition; Parenteral feeding; Electronic journals; Periodicals; Electronic journals; 615.854
• DOI: 10.1016/j.clnu.2015.11.006
• Languages: English
• ISSNs: 0261-5614

Abstract

Summary: Background & aims: Safety and growth adequacy of infant formulae enriched by functional ingredients need stringent evaluation by means of randomized controlled trials (RCTs), therefore we performed a double-blind RCT to evaluate an infant formula enriched with galacto-oligosaccharides, beta-palmitate, and acidified milk vs. a standard infant formula. Methods: Weight, length, head circumference and fecal bacteria (Bifidobacteria, BIF/Clostridia, CLO) were measured in healthy full term infants, at baseline – as before 21 days of life – at 60 and 135 days thereafter. A group of 51 neonates received the enriched formula (ENR), 59 the standard one (ST). Parents were trained to daily register gastrointestinal diseases. Results: All the infants grew homogeneously increasing the anthropometric parameters and complying with WHO and Italian standards: the mean (SD) difference in daily weight between ENR and ST groups was −0.74 (1.13) g/day, corresponding to a 90% CI of −2.62 to 1.13 g/day, well within the postulated interval of equivalence of −3.9 to +3.9 g/day. A statistical improvement in BIF concentration in the microbiota of infants fed by ENR was recorded. There was no between-group change in log10 CLO, but log10 BIF increase was higher at T2 vs. T0 in ENR (treatment × time interaction = 0.71, 95% CI 0.08–1.34, p = 0.028) than in ST neonates. This corresponds to estimated mean (95% CI) values of 8.37 (8.04–8.69) log10 -units for ENR vs. 8.08 (7.77–8.39) log10 -units for ST neonates. Gastrointestinal effects were mild and similar, with no statistical difference between two groups. Conclusion: Safety and growth ability of the enriched formula has been confirmed. A positive effect on neonatal gut microbiota, consisting of increased fecal BIF counts at T2 vs. baseline has been shown too. Nonetheless, larger RCTs are needed to estimate with greater precision the effective potential attributable to the enriched formula on neonatal microbiota, with particular reference to the mode of delivery. Highlights: Functional compounds are added to infant formulae to mimic benefits of breastfeeding. Safety, growth and functional efficiency need evaluation by controlled trials. We demonstrated safety and conformity to growth standard of an enriched formula. The enriched formula showed potential to increase gut Bifidobacteria. Early gut Bifidobacteria contribute to healthy life.